[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES8207217A1 - Procedimiento para la preparacion de un inactivador de alfa-amilasa - Google Patents

Procedimiento para la preparacion de un inactivador de alfa-amilasa

Info

Publication number
ES8207217A1
ES8207217A1 ES505959A ES505959A ES8207217A1 ES 8207217 A1 ES8207217 A1 ES 8207217A1 ES 505959 A ES505959 A ES 505959A ES 505959 A ES505959 A ES 505959A ES 8207217 A1 ES8207217 A1 ES 8207217A1
Authority
ES
Spain
Prior art keywords
inactivator
alpha
amylase
regulation
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES505959A
Other languages
English (en)
Other versions
ES505959A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803038130 external-priority patent/DE3038130A1/de
Priority claimed from DE19813107106 external-priority patent/DE3107106A1/de
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8207217A1 publication Critical patent/ES8207217A1/es
Publication of ES505959A0 publication Critical patent/ES505959A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN INACTIVADOR DE ALFA-AMILASA. CONSISTE EN CULTIVAR STREPTOMYCES TENDAE ATCC31210 O HAG 1266; A PARTIR DEL CULTIVO SE SEPARA EL INACTIVADOR CON AYUDA DE RESINAS DE ADSORCION O POR CROMATOGRAFIA DE FASE INVERTIDA Y A CONTINUACION SE PURIFICA, OBTENIENDOSE UN INACTIVADOR DE X''-AMILASA CONSISTENTE EN HOE 467-A CON UN PUNTO ISOELECTRICO 4,35,0,15 O BIEN HOE 467-B CON UN PUNTO ISOELECTRICO 4,53,0,15 O BIEN LOS DOS COMPONENTES. EL INACTIVADOR SEPARADO SE PURIFICA CON AYUDA DE INTERCAMBIADORES DE IONES A UN PH COMPRENDIDO ENTRE 4,4 Y 6. EL INACTIVADOR SEPARADO SE PURIFICA CON AYUDA DE INTERCAMBIADORES DE IONES A UN PH COMPRENDIDO ENTRE 4,4 PY 6.
ES505959A 1980-10-09 1981-10-02 Procedimiento para la preparacion de un inactivador de alfa-amilasa Granted ES505959A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803038130 DE3038130A1 (de) 1980-10-09 1980-10-09 (alpha) -amylaseinaktivatoren sowie verfahren zu ihrer herstellung
DE19813107106 DE3107106A1 (de) 1981-02-26 1981-02-26 (alpha) -amylaseinaktivator und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
ES8207217A1 true ES8207217A1 (es) 1982-09-01
ES505959A0 ES505959A0 (es) 1982-09-01

Family

ID=25788382

Family Applications (1)

Application Number Title Priority Date Filing Date
ES505959A Granted ES505959A0 (es) 1980-10-09 1981-10-02 Procedimiento para la preparacion de un inactivador de alfa-amilasa

Country Status (9)

Country Link
US (1) US4451455A (es)
EP (1) EP0049847B1 (es)
AU (1) AU542795B2 (es)
CA (1) CA1172978A (es)
DE (1) DE3169418D1 (es)
DK (1) DK446481A (es)
ES (1) ES505959A0 (es)
FI (1) FI813108L (es)
NO (1) NO813407L (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5885899A (ja) * 1981-11-16 1983-05-23 Fujirebio Inc アミラ−ゼインヒビタ−およびその製造法
DE3331860A1 (de) * 1983-09-03 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von tendamistat
FI844289L (fi) * 1984-01-21 1985-07-22 Hoechst Ag Nya polypeptider med -amylashaemmande verkan, foerfarande foer deras framstaellning, deras anvaendning och farmaceutiska preparat.
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
DE3536182A1 (de) * 1985-10-10 1987-04-16 Hoechst Ag Promotor-anordnung fuer streptomyceten-vektoren
WO1996012730A1 (en) * 1994-10-20 1996-05-02 Industrial Research Limited Separation of amino acids and peptides from protein hydrolysates
US7829552B2 (en) 2003-11-19 2010-11-09 Metabasis Therapeutics, Inc. Phosphorus-containing thyromimetics
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
AU2005308575A1 (en) * 2004-11-23 2006-06-01 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as HMG Co-A reductase inhibitors for the treatment of lipidemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
EP2571860A1 (en) 2010-05-21 2013-03-27 Pfizer Inc 2-phenyl benzoylamides
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2828343A1 (en) 2011-03-04 2012-09-13 The Scripps Research Institute Edn3-like peptides and uses thereof
US20150050371A1 (en) 2012-03-09 2015-02-19 Biotropics Malaysia Berhad Extract Formulations of Rhodamnia Cinerea And Uses Thereof
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
RU2618628C1 (ru) 2013-04-17 2017-05-05 Пфайзер Инк. Производные N-пиперидин-3-илбензамида для лечения сердечно-сосудистых заболеваний
EP3004138B1 (en) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
AU2015308350B2 (en) 2014-08-29 2020-03-05 Tes Pharma S.R.L. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
KR20190065312A (ko) 2016-10-14 2019-06-11 테스 파마 에스.알.엘. 알파-아미노-베타-카복시뮤콘산 세미알데하이드 데카복실라제의 저해제
AU2019385644A1 (en) 2018-11-20 2021-06-03 Tes Pharma S.R.L. Inhibitors of α-Amino-β-carboxymuconic acid semialdehyde decarboxylase
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5125232B1 (es) * 1965-02-24 1976-07-29
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung

Also Published As

Publication number Publication date
DE3169418D1 (en) 1985-04-25
FI813108L (fi) 1982-04-10
AU542795B2 (en) 1985-03-14
EP0049847A2 (de) 1982-04-21
NO813407L (no) 1982-04-13
EP0049847A3 (en) 1982-08-25
US4451455A (en) 1984-05-29
AU7615081A (en) 1982-04-22
CA1172978A (en) 1984-08-21
DK446481A (da) 1982-04-10
ES505959A0 (es) 1982-09-01
EP0049847B1 (de) 1985-03-20

Similar Documents

Publication Publication Date Title
ES8207217A1 (es) Procedimiento para la preparacion de un inactivador de alfa-amilasa
DE3260794D1 (en) Cyclic carbonic acid derivatives, process for their preparation and their use as copolymerisation constituents for the preparation of polycarbonates
IL75637A0 (en) Thymopentin analogs and pharmaceutical compositions containing them
GB2146338B (en) Cell membrane proteins
IL67572A (en) Trans-2-aza bicyclo(3.(3+n).o)alkane-3-carboxylic acid derivatives,processes for their preparation and pharmaceutical compositions containing them
GEP20084347B (en) New derivatives of diphosphonic acid, method for their preparation and medicamentous form containing them
EP0263569A3 (en) 9-alpha-hydroxysteroids,process for their preparation,process for the preparation of the corresponding 9(11)-dehydro-derivatives and pharmaceutical preparations containing said steroids
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
WO1993016719A3 (en) Use of platelet derived growth factor in ophthalmic wound healing
AU3062384A (en) Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
SG102892G (en) Composition of pregnanolole comprising a stable oil-in-water emulsion
AU2674288A (en) Process for the preparation of diorganopolysiloxanes containing triorganosiloxy groups as terminal units
AU1082988A (en) 5-hydroxy-3-aminochroman compounds, processes for their preparation, pharmaceutical compositions containing them and methods of treatment therewith
DK583785D0 (da) Soedemiddel, fremgangsmaade til fremstilling deraf og anvendelse deraf
EP0331755A4 (en) Medicine-containing fat emulsion of the type prepared immediately before use and process for preparing medicine-containing fat emulsion
EG18005A (en) Composition of the activation of fermentative processes and process for the acceleration of the fermentative degradation of natural products
ES8600752A1 (es) Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida.
HUT45972A (en) Process for production of derivatives of subsituated amin-methil-5,6,7,8-tetrahydronaphtil-oxi-acetic acid, of medical compositions containing such substances and also of the intermediers
ES8304152A1 (es) Procedimiento para la obtencion de derivzados de aminociclitol.
GB2109796B (en) Anorexigenic tripeptides, process for the preparation thereof and pharmaceutical compositions containing them
PT83984A (en) Process for the preparation of novel 16,17-acetalsubstituted pregnane 21-oic derivatives and of pharmaceutical compositions containing the same
DE3160797D1 (en) 11-alpha-amino androstanes, pharmaceutical compositions containing them and processes for their preparation
IL81213A (en) Fluorinated diaminoalkyne derivatives,process for their preparation and pharmaceutical compositions containing them
AU8019294A (en) Methodologies for extracting and using muira puama
US3098792A (en) Process for preparing product having enhanced lactogenic activity

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980504